Safety Profile - Scemblix
Below is a selection of the observed side effects. Please refer to the SmPc for the complete list.
The most common adverse reactions of any grade (incidence ≥20%) in patients receiving asciminib were musculoskeletal pain (37.1%), upper...Twitter Linkedin Facebook Pinterest Google plusReimbursement - Jakavi
Tafinlar® + Mekinist® Patient Brochure - NSCLC (Dutch)
Patient brochure covering all the basics about their treatment for BRAF+ NSCLC, with a tear-off calendar in the back.Can only be given by an HCP to the patient once the patient has been prescribed Taf/Mek (so no use at general patient days/PAG days)...Melanoma: BRAF mutation brochure (Dutch)
Guide for patient/General public with more information regarding the BRAF mutation in melanoma Download Dutch documentTafinlar® + Mekinist® Patient Brochure - Adjuvant Melanoma (French)
Patient brochure covering all the basics about their treatment in ADJUVANT melanoma, with a tear-off calendar in the back.Can only be given by an HCP to the patient once the patient has been prescribed Taf/Mek (so no use at general patient days/PAG days...Heart Failure
Patient Resources - Entresto
Together for Better In the fight against heart failure condition, we work our hardest every day to develop innovative and effective medication to sustain a better life, keeping the patient in mind. We are aware that the result of...
Twitter Linkedin Facebook Pinterest Google plusIndications - Cosentyx PsA
Cosentyx (generic name: secukinumab) is a medication used to treat several autoimmune conditions. Here are the key indications for Cosentyx:
1. Plaque Psoriasis:
For adults with moderate to severe...
Twitter Linkedin Facebook Pinterest Google plusEfficacy - Cosentyx PsA
×